However, E2 exerts both beneficial and adverse effects on cancer depending on the estrogen receptor subtype (i.e., ERα and ERβ) expressed.1, 2, 3 Indeed, ERα promotes the proliferation of breast, gynecologic, and endocrine gland cancers. Here, ESR1 is linked to malignant endocrine neoplasm.